Sangamo BioSciences

How Sangamo BioSciences, Inc. Is Partnering to Success
Motley Fool
Fri, 01/31/14 - 08:15 am
Sangamo BioSciences
zinc-finger proteins
Shire
Biogen Idec
The State of Gene Therapy in a Biogen Idec World: Sangamo, Bluebird and Acceleron
TheStreet.com
Thu, 01/23/14 - 09:53 am
gene therapy
Biogen Idec
Sangamo BioSciences
Bluebird Bio
Acceleron
3 Lessons From the Biggest Biotech Event of 2014
Motley Fool
Thu, 01/23/14 - 08:18 am
biotech
JPMHC 2014
Sangamo BioSciences
Biogen Idec
Amag Pharmaceuticals
Portola Pharmaceuticals
The Best- And Worst-Performing Biotech Stocks,Jan. 3 to Jan. 10
Forbes
Sat, 01/11/14 - 10:13 am
Neurocrine
Intercept Pharma
Epizyme
Sangamo BioSciences
OncoMed
Zogenix
Macrogenics
Intrexon
Pharmacyclics
Galena Biopharma
Biogen to Develop Blood Medicines in Deal With Sangamo
Bloomberg
Thu, 01/9/14 - 09:33 am
Biogen Idec
Sangamo BioSciences
beta-thalassemia
sickle cell disease
Keep a Close Watch on Geron, Keryx, and Sangamo Today
Motley Fool
Fri, 12/6/13 - 10:21 am
Geron
Keryx
Sangamo BioSciences
Sangamo Engineering Genetic Cures
Seeking Alpha
Wed, 07/10/13 - 01:24 pm
Sangamo BioSciences
When It Comes To Biotech, Diversity Is Key
Seeking Alpha
Wed, 06/12/13 - 09:03 am
biotech
Alkermes
Celgene
AstraZeneca
Coronado Biosciences
Dendreon
Incyte
Isis Pharmaceuticals
JNJ
Eli Lilly
Merck
Novavax
Novartis
Pfizer
Sangamo BioSciences
Pharmacyclics
Sangamo BioSciences Receives $6.4 Million Strategic Partnership Award From California Institute for Regenerative Medicine (CIRM) to Develop ZFP Therapeutic for Beta-thalassemia
Yahoo/PR NewsWire
Fri, 05/24/13 - 10:44 am
Sangamo BioSciences
beta-thalassemia
stem cells
ZFP Therapeutic
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Seeking Alpha
Sat, 05/4/13 - 10:32 am
Vertex Pharmaceuticals
Pharmacyclics
Novartis
Celsion
Peregrine Pharmaceuticals
Prana
Navidea Biopharmaceuticals
Cardinal Health
ONYX Pharmaceuticals
Bayer
Sarepta
Hyperion Therapeutics
Amarin
Medivation
Astellas
JNJ
Trius
Sangamo BioSciences
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tue, 04/2/13 - 10:58 am
Arena Pharmaceuticals
Zogenix
Delcath
Aveo Pharmaceutical
Vivus
Titan Pharmaceuticals
Bristol-Myers Squibb
Merck
Gilead
AbbVie
Amarin
Achillion
Sangamo BioSciences
Raptor Pharmaceuticals
Vertex Pharmaceuticals
NewLink Genetics
AstraZeneca
Rigel
Depomed
Biogen Idec
Sucampo
Dendreon
Valeant Pharmaceuticals
GSK
Aegerion
Sangamo Biosciences Hits Multi-Year Highs
Seeking Alpha
Tue, 03/19/13 - 11:08 am
Sangamo BioSciences
Sangamo BioSciences: A Biotech Not To Be Shorted
Seeking Alpha
Tue, 01/15/13 - 11:41 am
Sangamo BioSciences
[video] The Next Big Thing In Biotech: Ligand, BioMarin & Sangamo
TheStreet.com
Fri, 11/30/12 - 12:11 pm
Biomarin
Sangamo BioSciences
Ligand
3 Speculative Biotechs Worth Watching
Seeking Alpha
Sun, 07/8/12 - 01:07 pm
OncoSec
Vical
Sangamo BioSciences
Sangamo BioSciences' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Seeking Alpha
Thu, 02/9/12 - 09:29 am
Sangamo BioSciences
earnings
20 Biotech Stocks That Hedge Funds Are Selling
Seeking Alpha
Sun, 12/11/11 - 02:40 pm
Nabi
Pacific Biosciences
Dendreon
Momenta
Enzon
Acorda Therapeutics
ShangPharma
Charles River Laboratories
Sangamo BioSciences
BioSpecifics Technologies
Jazz Pharmaceuticals
Amgen
Sinovac Biotech
ViroPharma
Vanda
Insmed
Transcept
Cadence Pharmaceuticals
PDL Biopharma
Chelsea Therapeutics
Biologic Drugs: A Fast Growing Industry In The Making
Seeking Alpha
Wed, 11/30/11 - 09:13 am
biologics
Abbott Laboratories
Biogen Idec
Impax
Sangamo BioSciences
11 Biotech Stocks With Bullish Short Trends
Seeking Alpha
Wed, 11/23/11 - 11:14 am
Biomarin
BioSpecifics Technologies
Complete Genomics
Incyte
Medivation
Insmed
Momenta
Questcor
Seattle Genetics
Sangamo BioSciences
XenoPort
Sangamo Nerve Regrowth Drug Fails Key Test
TheStreet.com
Mon, 10/3/11 - 10:40 am
nerve regrowth
Sangamo BioSciences
SB-509
diabetic neuropathy

Pages